首页 正文

Biomaterial-based immunoengineering to fight COVID-19 and infectious diseases

{{output}}
Infection by SARS-CoV-2 virus often induces the dysregulation of immune responses, tissue damage, and blood clotting. Engineered biomaterials from the nano- to the macroscale can provide targeted drug delivery, controlled drug release, local immunomodulation, ... ...